AI assistant
Sending…
GREIF, INC — Director's Dealing 2024
Jan 18, 2024
31415_dirs_2024-01-18_9cd8e207-137d-437f-85f0-0dfc9f3cbd3f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GREIF, INC (GEF,GEF.B)
CIK: 0000043920
Period of Report: 2024-01-16
Reporting Person: MARTZ GARY R (Executive VP & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-16 | Class A Common Stock | M | 9227 | — | Acquired | 105234.3981 | Direct |
| 2024-01-16 | Class A Common Stock | F | 3631 | — | Disposed | 101603.3981 | Direct |
| 2024-01-16 | Class A Common Stock | A | 30300 | — | Acquired | 131903.3981 | Direct |
| 2024-01-16 | Class A Common Stock | F | 9672 | — | Disposed | 122231.3981 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-01-16 | Restricted Stock Unit | $0 | M | 9227 | Disposed | Class A Common Stock (9227) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class B Common Stock | 8100 | Direct |
Footnotes
F1: Includes 357.3981 shares of Class A Common Stock acquired in December 29, 2023 under the Greif, Inc. Colleague Stock Purchase Plan
F2: Performance Shares awarded pursuant to the Company's Long Term Incentive Plan. No consideration was paid by the reporting person. Shares are subject to a one year restriction on transfer.
F3: Each restricted stock unit represents a contingent right to receive one share of Class A common stock on the third anniversary of the grant date.
More from GREIF, INC
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 25